Schechter Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$442K Buy
17,456
+9,079
+108% +$238K 0.04% 397
2024
Q4
$222K Sell
8,377
-15,904
-65% -$431K 0.02% 551
2024
Q3
$703K Buy
24,281
+372
+2% +$10.9K 0.05% 322
2024
Q2
$669K Buy
23,909
+10,697
+81% +$295K 0.05% 315
2024
Q1
$367K Sell
13,212
-860
-6% -$23.9K 0.03% 451
2023
Q4
$405K Sell
14,072
-222
-2% -$6.71K 0.04% 392
2023
Q3
$474K Sell
14,294
-14,300
-50% -$506K 0.05% 356
2023
Q2
$1.05M Buy
28,594
+7,489
+35% +$291K 0.09% 233
2023
Q1
$861K Sell
21,105
-13,248
-39% -$572K 0.08% 288
2022
Q4
$1.76M Buy
34,353
+9,853
+40% +$472K 0.16% 140
2022
Q3
$1.07M Sell
24,500
-6,174
-20% -$300K 0.11% 254
2022
Q2
$1.61M Buy
30,674
+4,233
+16% +$216K 0.16% 133
2022
Q1
$1.37M Buy
26,441
+2,016
+8% +$105K 0.13% 196
2021
Q4
$1.44M Buy
+24,425
New +$1.21M 0.13% 197

Other funds holding PFE

Schechter Investment Advisors's PFE Position: Q1 2025 in Review

Schechter Investment Advisors increased its Pfizer (PFE) stake by 108% in Q1 2025, buying an estimated $238K and bringing the position to 17,456 shares worth $442K. The position accounts for 0.04% of the portfolio, ranked #397.

Schechter Investment Advisors first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.76M in Q4 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Schechter Investment Advisors held 17,456 shares of Pfizer worth $442K as of Q1 2025.
  • Schechter Investment Advisors bought 9,079 Pfizer shares in Q1 2025, an estimated $238K.
  • Pfizer made up 0.04% of Schechter Investment Advisors's portfolio in Q1 2025, its #397 holding.
  • Schechter Investment Advisors first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
  • Schechter Investment Advisors's Pfizer position peaked at $1.76M in Q4 2022.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.